AnaptysBio Inc (ANAB)
21.18
+0.88
(+4.31%)
USD |
NASDAQ |
Nov 21, 16:00
21.18
0.00 (0.00%)
After-Hours: 20:00
AnaptysBio Price to Book Value: 7.641 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 7.325 |
| November 19, 2024 | 7.203 |
| November 18, 2024 | 6.810 |
| November 15, 2024 | 6.853 |
| November 14, 2024 | 7.275 |
| November 13, 2024 | 7.484 |
| November 12, 2024 | 7.754 |
| November 11, 2024 | 8.079 |
| November 08, 2024 | 7.686 |
| November 07, 2024 | 7.751 |
| November 06, 2024 | 8.010 |
| November 05, 2024 | 7.170 |
| November 04, 2024 | 7.192 |
| November 01, 2024 | 7.819 |
| October 31, 2024 | 7.801 |
| October 30, 2024 | 8.000 |
| October 29, 2024 | 11.11 |
| October 28, 2024 | 11.00 |
| October 25, 2024 | 11.55 |
| October 24, 2024 | 11.62 |
| October 23, 2024 | 12.53 |
| October 22, 2024 | 12.68 |
| October 21, 2024 | 12.76 |
| October 18, 2024 | 12.62 |
| October 17, 2024 | 12.69 |
| Date | Value |
|---|---|
| October 16, 2024 | 12.51 |
| October 15, 2024 | 12.00 |
| October 14, 2024 | 12.53 |
| October 11, 2024 | 11.98 |
| October 10, 2024 | 11.54 |
| October 09, 2024 | 11.34 |
| October 08, 2024 | 11.67 |
| October 07, 2024 | 11.90 |
| October 04, 2024 | 12.26 |
| October 03, 2024 | 12.63 |
| October 02, 2024 | 12.62 |
| October 01, 2024 | 12.55 |
| September 30, 2024 | 12.08 |
| September 27, 2024 | 97.43 |
| September 26, 2024 | 99.38 |
| September 25, 2024 | 98.86 |
| September 24, 2024 | 106.63 |
| September 23, 2024 | 108.74 |
| September 20, 2024 | 117.63 |
| September 19, 2024 | 114.73 |
| September 18, 2024 | 111.79 |
| September 17, 2024 | 114.64 |
| September 16, 2024 | 118.37 |
| September 13, 2024 | 123.29 |
| September 12, 2024 | 117.08 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7749
Minimum
Nov 22 2019
123.29
Maximum
Sep 13 2024
8.096
Average
2.295
Median
Price to Book Value Benchmarks
| Eli Lilly and Co | 49.99 |
| Regeneron Pharmaceuticals Inc | 2.790 |
| Ligand Pharmaceuticals Inc | 2.626 |
| Agios Pharmaceuticals Inc | 1.948 |
| ADMA Biologics Inc | 21.71 |
Price to Book Value Related Metrics
| PS Ratio | 10.16 |
| PEG Ratio | -0.2861 |
| Price | 21.18 |
| Earnings Yield | -28.70% |
| Market Cap | 644.63M |
| PEGY Ratio | -0.2861 |